|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.05 EUR | -0.28% |
|
+1.05% | -0.47% |
| 12-30 | Eurazeo SE's Equity Buyback announced on March 6, 2025, has expired. | CI |
| 12-19 | Eurazeo Sells Assets from Its Elevate Strategy |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.74 | 9.82 | 3.96 | 0.35 | -2.28 | |||||
Return on Total Capital | 3.55 | 12.61 | 5.07 | 0.42 | -2.39 | |||||
Return On Equity % | -4.56 | 26.26 | 5.54 | 21.02 | -5.28 | |||||
Return on Common Equity | -3.32 | 29.29 | 9.42 | 25.03 | -5.6 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 68.28 | 75.27 | 70.7 | 76.63 | -1.54K | |||||
SG&A Margin | 41.91 | 32.11 | 41.45 | 44.87 | 3.36K | |||||
EBITDA Margin % | 23.11 | 40.62 | 25.88 | 23.08 | -5.72K | |||||
EBITA Margin % | 19.78 | 37.82 | 23.66 | 22.17 | -5.78K | |||||
EBIT Margin % | 13.77 | 34.8 | 19.72 | 20.07 | -5.93K | |||||
Income From Continuing Operations Margin % | -6.55 | 28.14 | 8.66 | 457.63 | -7.11K | |||||
Net Income Margin % | -3.62 | 23.32 | 10.53 | 450.5 | -7.28K | |||||
Net Avail. For Common Margin % | -3.63 | 23.48 | 10.54 | 450.5 | -7.28K | |||||
Normalized Net Income Margin | 7.37 | 14.87 | 9.9 | -2.85 | -4.57K | |||||
Levered Free Cash Flow Margin | 3.59 | 33.09 | 1.11 | -58.92 | -4.02K | |||||
Unlevered Free Cash Flow Margin | 7.21 | 35.72 | 4.89 | -50.35 | -3.2K | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.32 | 0.45 | 0.32 | 0.03 | 0 | |||||
Fixed Assets Turnover | 2.34 | 3.99 | 3.12 | 0.4 | 0.08 | |||||
Receivables Turnover (Average Receivables) | 6.08 | 8.44 | 7.7 | 0.74 | 1.7 | |||||
Inventory Turnover (Average Inventory) | 2.98 | 3.81 | 3.73 | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.31 | 1.28 | 1.05 | 0.38 | 0.26 | |||||
Quick Ratio | 0.78 | 0.96 | 0.75 | 0.36 | 0.24 | |||||
Operating Cash Flow to Current Liabilities | 0.11 | 0.11 | 0.09 | -0.01 | 0.04 | |||||
Days Sales Outstanding (Average Receivables) | 60.17 | 43.24 | 47.39 | 495.74 | 215.55 | |||||
Days Outstanding Inventory (Average Inventory) | 122.85 | 95.73 | 97.75 | - | - | |||||
Average Days Payable Outstanding | 141.1 | 106.12 | 101.07 | - | 287.68 | |||||
Cash Conversion Cycle (Average Days) | 41.91 | 32.85 | 44.07 | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 74.16 | 51.59 | 59.05 | 11.26 | 19 | |||||
Total Debt / Total Capital | 42.58 | 34.03 | 37.13 | 10.12 | 15.96 | |||||
LT Debt/Equity | 67.67 | 49.25 | 52.92 | 1.91 | 3.66 | |||||
Long-Term Debt / Total Capital | 38.85 | 32.49 | 33.27 | 1.71 | 3.08 | |||||
Total Liabilities / Total Assets | 55.97 | 48 | 50.78 | 14.46 | 19.86 | |||||
EBIT / Interest Expense | 2.38 | 8.29 | 3.26 | 1.46 | -4.52 | |||||
EBITDA / Interest Expense | 4.32 | 9.93 | 4.51 | 1.86 | -4.17 | |||||
(EBITDA - Capex) / Interest Expense | 3.65 | 9.37 | 3.44 | 1.85 | -4.37 | |||||
Total Debt / EBITDA | 4.09 | 1.54 | 3.55 | 9.1 | -4.44 | |||||
Net Debt / EBITDA | 2.91 | 0.9 | 2.85 | 7.63 | -4.06 | |||||
Total Debt / (EBITDA - Capex) | 4.83 | 1.63 | 4.66 | 9.16 | -4.24 | |||||
Net Debt / (EBITDA - Capex) | 3.44 | 0.96 | 3.74 | 7.68 | -3.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -14.09 | 52.96 | -16.46 | -92.83 | -98.54 | |||||
Gross Profit, 1 Yr. Growth % | -4.26 | 68.61 | -21.54 | -89.3 | -129.31 | |||||
EBITDA, 1 Yr. Growth % | 0.06 | 154.06 | -48.11 | -93.54 | -426.51 | |||||
EBITA, 1 Yr. Growth % | 8.84 | 192.66 | -47.71 | -92.64 | -489.18 | |||||
EBIT, 1 Yr. Growth % | 4.74 | 286.83 | -52.13 | -92.01 | -530.77 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -337.45 | -755.62 | -74.03 | 278.95 | -122.65 | |||||
Net Income, 1 Yr. Growth % | -240.86 | -1.08K | -62.11 | 206.79 | -123.56 | |||||
Normalized Net Income, 1 Yr. Growth % | 37.73 | 208.86 | -44.11 | -102.31 | 2.24K | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -243.87 | -1.07K | -62.42 | 210.62 | -123.28 | |||||
Accounts Receivable, 1 Yr. Growth % | -14.85 | -7.64 | 35.71 | -65.42 | -11.81 | |||||
Inventory, 1 Yr. Growth % | 5.53 | -18.51 | 25.1 | - | - | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.02 | -10.33 | 23.2 | -97.71 | 117.66 | |||||
Total Assets, 1 Yr. Growth % | -0.53 | 16.52 | 15.71 | -48.2 | -3.58 | |||||
Tangible Book Value, 1 Yr. Growth % | -49.83 | -245.3 | -272 | -1K | -10.82 | |||||
Common Equity, 1 Yr. Growth % | -6.9 | 31.89 | 5.16 | 25.12 | -10.41 | |||||
Cash From Operations, 1 Yr. Growth % | -37.18 | 5.03 | -19.7 | -104.57 | -693.38 | |||||
Capital Expenditures, 1 Yr. Growth % | -25.08 | -8.07 | 133.26 | -99.82 | 2.24K | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -79.08 | 1.56K | -97.22 | -10.74K | -0.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -64.63 | 719.67 | -88.6 | -194.44 | -7.42 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 16.67 | 25.71 | 10 | 9.5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.23 | 14.63 | 13.04 | -75.52 | -96.77 | |||||
Gross Profit, 2 Yr. CAGR % | 2.2 | 27.06 | 15.02 | -75.3 | -82.29 | |||||
EBITDA, 2 Yr. CAGR % | 0.45 | 64.03 | 16.28 | -81.78 | -51.69 | |||||
EBITA, 2 Yr. CAGR % | -0.18 | 78.41 | 23.67 | -81.25 | -47.11 | |||||
EBIT, 2 Yr. CAGR % | -3.01 | 101.18 | 35.34 | -81.31 | -41.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 7.99 | 294.99 | 29.83 | -0.8 | -7.35 | |||||
Net Income, 2 Yr. CAGR % | -19.3 | 272.72 | 92.5 | 7.81 | -14.99 | |||||
Normalized Net Income, 2 Yr. CAGR % | -4.67 | 106.13 | 31.04 | -89.26 | -26.43 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -23.05 | 273.76 | 90.64 | 8.04 | -14.97 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.77 | -11.32 | 11.96 | -31.49 | -44.77 | |||||
Inventory, 2 Yr. CAGR % | 15.69 | -7.27 | 0.97 | - | - | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.39 | -10.18 | 5.75 | -83.19 | -77.65 | |||||
Total Assets, 2 Yr. CAGR % | 6.84 | 7.66 | 16.75 | -22.58 | -29.33 | |||||
Tangible Book Value, 2 Yr. CAGR % | 738.94 | -15.79 | 36.37 | 293.6 | 183.42 | |||||
Common Equity, 2 Yr. CAGR % | -4.13 | 10.97 | 17.71 | 14.71 | 5.87 | |||||
Cash From Operations, 2 Yr. CAGR % | 11.53 | -18.77 | -8.16 | -80.85 | -47.93 | |||||
Capital Expenditures, 2 Yr. CAGR % | -2.67 | -17.01 | 46.43 | -93.52 | -79.49 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -27.3 | 71.67 | -31.82 | -67.41 | 928.59 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.49 | 63.7 | -3.16 | -71 | -6.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | 12.25 | - | 21.11 | 17.59 | 9.75 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.23 | 11.17 | 3.16 | -54.91 | -90.44 | |||||
Gross Profit, 3 Yr. CAGR % | 6.3 | 20.76 | 8.2 | -53.15 | -73.85 | |||||
EBITDA, 3 Yr. CAGR % | 3.27 | 39.48 | 12.71 | -55.78 | -50.7 | |||||
EBITA, 3 Yr. CAGR % | 2.12 | 42.83 | 18.49 | -53.15 | -48.89 | |||||
EBIT, 3 Yr. CAGR % | -5.53 | 53.76 | 24.21 | -48.87 | -46.81 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -18.09 | 97.15 | 58.89 | 85.55 | -39.36 | |||||
Net Income, 3 Yr. CAGR % | -30.65 | 85.89 | 73.69 | 124.85 | -35.06 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.57 | 41.01 | 33.18 | -67.15 | -35.39 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -29.1 | 79.15 | 73.79 | 124.33 | -35.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | -6.45 | -5.74 | 2.19 | -24.32 | -25.48 | |||||
Inventory, 3 Yr. CAGR % | 12.01 | 2.93 | 2.47 | - | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.03 | 3.62 | 0.2 | -70.5 | -60.52 | |||||
Total Assets, 3 Yr. CAGR % | 6.14 | 9.97 | 10.68 | -10.95 | -16.71 | |||||
Tangible Book Value, 3 Yr. CAGR % | 133.96 | 363.34 | -3.18 | 155.86 | 139.96 | |||||
Common Equity, 3 Yr. CAGR % | -0.97 | 6.73 | 8.96 | 20.13 | 5.64 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.32 | 9.32 | -19.08 | -66.22 | -39.84 | |||||
Capital Expenditures, 3 Yr. CAGR % | 5.73 | -4.51 | 17.12 | -84.31 | -53.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -16.69 | 95.27 | -56.48 | 21.04 | -52.74 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -5.65 | 79.68 | -32.57 | -11.54 | -57.29 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.78 | 13.7 | - | 17.28 | 14.83 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.13 | 17.57 | 7.05 | -39.31 | -74.18 | |||||
Gross Profit, 5 Yr. CAGR % | -0.54 | 19.03 | 9.71 | -35.99 | -50.79 | |||||
EBITDA, 5 Yr. CAGR % | -12.51 | 20.18 | 9.53 | -37.9 | -19.85 | |||||
EBITA, 5 Yr. CAGR % | -14.98 | 19.64 | 10.24 | -36.61 | -15.74 | |||||
EBIT, 5 Yr. CAGR % | -20.64 | 18.91 | 9.06 | -33.96 | -9.64 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -28.46 | 24.01 | -1.48 | 49.49 | 28.06 | |||||
Net Income, 5 Yr. CAGR % | -34 | 24.85 | 4.41 | 49.36 | 30.52 | |||||
Normalized Net Income, 5 Yr. CAGR % | -16.75 | 16.95 | 12.44 | -49.71 | 2.66 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -32.02 | 26.82 | 5.39 | 46.34 | 30.57 | |||||
Accounts Receivable, 5 Yr. CAGR % | 29.62 | 4.71 | 0.52 | -17.03 | -20.11 | |||||
Inventory, 5 Yr. CAGR % | 42.82 | 12.02 | 7.45 | - | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 67.4 | 8.02 | 9.47 | -49.81 | -45.02 | |||||
Total Assets, 5 Yr. CAGR % | 13.4 | 9.2 | 10.27 | -4.22 | -7.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | -32.2 | -17.76 | 87.48 | 309.16 | 48.78 | |||||
Common Equity, 5 Yr. CAGR % | 1.54 | 6.56 | 6.18 | 9.83 | 7.71 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.15 | 18.11 | 5.28 | -45.54 | -32.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 32.74 | -17.36 | 20.44 | -67.44 | -41.66 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -41.28 | 41.51 | -25.61 | -4.5 | -20.76 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -33.21 | 38.72 | -6.15 | -13.3 | -26.84 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.73 | 11.04 | 14.18 | 15.24 | - |
- Stock Market
- Equities
- RF Stock
- Financials Eurazeo SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















